Publication | Closed Access
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.
111
Citations
22
References
2002
Year
These data confirm that thalidomide is active in patients with advanced relapsed/refractory MM and represent the basis for ongoing clinical trials aimed at testing the role of this drug as front line therapy for newly diagnosed disease.
| Year | Citations | |
|---|---|---|
Page 1
Page 1